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Abstract
At the turn of the 19
th century, trypanosomes were identified as the causative agent of sleeping sickness and their presence
within the cerebrospinal fluid of late stage sleeping sickness patients was described. However, no definitive proof of how
the parasites reach the brain has been presented so far. Analyzing electron micrographs prepared from rodent brains more
than 20 days after infection, we present here conclusive evidence that the parasites first enter the brain via the choroid
plexus from where they penetrate the epithelial cell layer to reach the ventricular system. Adversely, no trypanosomes were
observed within the parenchyma outside blood vessels. We also show that brain infection depends on the formation of long
slender trypanosomes and that the cerebrospinal fluid as well as the stroma of the choroid plexus is a hostile environment
for the survival of trypanosomes, which enter the pial space including the Virchow-Robin space via the subarachnoid space
to escape degradation. Our data suggest that trypanosomes do not intend to colonize the brain but reside near or within
the glia limitans, from where they can re-populate blood vessels and disrupt the sleep wake cycles.
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Introduction
Human African Trypanosomiasis (HAT) has been documented
at least since medieval times (13
th century) during which its
characteristic symptoms (especially sleepiness during daytime)
were described by Arabian historians [1]. Descriptions of HAT
cases are also well known from times of the slavery tragedy [2] and
the first recorded disastrous outbreak of this disease between 1896
and 1906 [3]. Ever since, epidemic outbreaks of this plague were
monitored at irregular intervals. Periods of delusive safety always
lead to the impression of a nearly eradicated disease. However,
although the last outbreak, especially in the Democratic Republic
of Congo and Uganda [3], is only some 15 years ago, the currently
available drugs (suramin, melarsoprol, pentamidin, eflornithine
and recently the combination of nifurtimox and eflornithine) are at
least 45 years old and far from being a safe, easy to use, cost-
effective and specific treatment, leaving aside the development of
resistant strains [4].
HAT is characterized by an early blood and a late brain stage.
The blood stage has been extensively documented and is well
understood [5]. During this stage, the parasites are protected from
the host’s immune response by expressing a surface coat consisting
of about 10
7 identical protein molecules known as variant surface
glycoprotein (VSG). Since VSG specific antibodies appear in
about 10 day intervals, the cell density of parasites in blood is
primarily controlled by removal of opsonized trypanosomes,
leading to cyclical waves of infection. However, because of
antigenic variation [6,7], HAT is never completely controlled and
inevitably fatal if untreated. Amongst the more than 100
trypanosome species, only Trypanosoma brucei gambiense and T.b.
rhodesiense are known to cause chronic or acute form of sleeping
sickness, respectively. In the first case it takes months to years, in
the latter case weeks to months before parasites appear in brain
and induce typical sleeping sickness symptoms such as drowsiness
at daytime and insomnia at night, headache, fever, general
malaise, slurred speech and changes of personality [8]. When
untreated, patients die usually by emaciation, uncontrolled
bacterial infection, sometimes acute brain inflammation, but most
commonly heart failure [9,10].
David Bruce was the first to report that Trypanosoma brucei are
transmitted by tsetse flies [11], before Aldo Castellani found the
protozoan parasite within the cerebrospinal fluid (csf) of sleeping
sickness patients [12]. However, phylogenetic gene comparisons
have shown that salivarian trypanosomes emerged already some
300 million years ago and became midgut parasites of insects [13].
There is no obvious reason why trypanosomes enter the brain of
infected mammals, because here they cannot be taken up by tsetse
flies during a blood meal. In terms of an evolutionary pressure, one
may consider that parasites within the brain are hidden from the
major parts of the immune system as a reservoir in case of an
eradication of blood parasites. It seems also plausible to assume
that sleepiness during daytime increases the chances of trypano-
somes to be transmitted to the insect. Tsetse flies are pool feeders,
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34304i.e. they cut the skin and suck up blood from the respective lesion.
This bite is rather painful and sufficient feeding takes time. Since
man can reach virtually any part of the body with his hands,
feeding would be more effective if the respective person does not
react. Interestingly, prostaglandin D2, which induces non-rem
sleep if injected into the ventricle system [14], is significantly
increased in csf of late stage patients [15]. Trypanosomes are able
to produce PGD2 [16] that they also use for cell density regulation
[17]. During evolution, infection of the brain may thus have
proven as an advantage for the parasite’s epidemiological
distribution.
The way how trypanosomes enter the brain is still controver-
sially discussed. Two possible gates exist, the blood-brain barrier
(BBB) and the blood-csf barrier (BCB). Data and arguments have
been presented for both options [18,19], although it is now
generally believed that trypanosomes do initially cross the BCB.
While in human infections the parasites appear in brain with a
latency of at least weeks, in experimental lab infections of rats or
mice more than 20 days are needed to detect trypanosomes there
[19,20,21]. During that time, several waves of high and low
parasitaemia have passed where the seal proofed tight. Obviously,
it is thus not simply a question of parasite density in blood that
pushes the door open but the physiological condition, which may
change in time to allow access. The BBB is formed by endothelial
cells connected by tight junctions and lined up along a basal
lamina of the brain’s blood vessels. On the brain side of the vessel,
astrocyte feet attach also to the basal lamina and form an
additional cellular layer of the BBB [22], the glia limitans.I n
contrast, the BCB does not contain a glia limitans and consists of
two spatially isolated cellular barriers: 1) Fenestrated endothelial
cells line out the capillaries of the choroid plexus and attach to a
basal lamina; 2) Epithelial cells forming the surface of the choroid
plexus [23]. The latter cells are also based on a basal lamina and
are interconnected by a specific type of tight junctions containing
claudin 11 [24]. Stroma, i.e. the space between the fenestrated
endothelial cells and the plexus epithelia cells, contain connective
tissue cells and phagocytes. By passing through the four choroid
plexuses, cell-free blood becomes csf that is finally released into the
ventricles. The lateral ventricles are connected via the interven-
tricular foramen to the third ventricle and via the cerebral
aqueduct to the fourth ventricle. From here, pulsating currents
forward csf to the subarachnoid space and the spinal cord.
We here show that trypanosomes are able to cross the BCB and
can be located 20 days post infectionem (p.i.) within the stroma of the
choroid plexus as well as inside ventricles. In contrast, we could
not detect parasites in the surroundings of blood vessels belonging
to the BBB, although they were clearly visible within these vessels.
Based on our experimental data obtained so far, we show that
African trypanosomes enter the brain via the choroid plexus and
settle initially in the pia mater area.
Results
Brain infection following intrathecal injection
We used trypanosomes of the pleomorphic strain AnTAT 1.1
and Wistar rats as animal models. To induce a brain infection,
animals were either intraperitoneally infected or subjected to an
intrathecal injection of parasites. For the latter, 10
4 trypanosomes
in 5 ml were injected either into the striatum (7 rats) or into one
lateral ventricle (7 rats). The infected rats have then been observed
for 10 days (10 rats) or 14 days (4 rats), respectively, and monitored
for behavior and blood infection. Afterwards, isolated brains have
been analyzed for parasite distribution. The results of these
experiments showed that although the glass capillary orifice was
clearly visible by microscopic analysis, trypanosomes could not be
detected in the vicinity of this area or elsewhere in the brain.
Furthermore, observation of the animals showed no obvious
disturbances in activities such as phenotypic behavior, changes in
food intake or locomotion (data not shown). Interestingly, no
animals that received trypanosomes into the striatum showed a
blood infection during the observed experimental time (10 or 14
days), while 6 out of the 7 infected rats that received trypanosomes
into the ventricle showed a blood infection 3 or 4 days p.i.,a s
confirmed by tail biopsy. These results clearly suggest that
bloodstream form trypanosomes cannot simply enter the paren-
chyma or csf to induce a brain infection. A retro infection of blood
from csf, however, is likely to occur, although we cannot rule out
the possibility that during ventricle application in contrast to
striatum application blood vessels had been injured.
Brain infection after blood injection
In nature brain infection occurs only after a prolonged time of
blood infection. To analyze brain infection in the animal model,
rats were infected by intra-peritoneal injection of 10
7 trypano-
somes in 1 ml citrate-glucose anticoagulant (CGA). Blood
parasitaemia was monitored daily by tail bleeding and brains of
infected rats were isolated from sacrificed animals between day 5
and 35 p.i.
Although parasites were visible within blood vessels at all times,
trypanosomes were never detected in the parenchyma outside the
vessels (Fig. 1a). This was completely different in case of the plexus
area. Comparing peak population densities and brain appearance,
we confirmed earlier observations [19,20,21] that it takes about 20
days (corresponding to about 3 parasitic waves) until trypanosomes
appear in the choroid plexus, independent of the parasite’s titer.
Whenever the brain was isolated after 20 days p.i. or later,
trypanosomes, but no blood cells, were clearly visible inside the
plexus, i.e. within stroma (Fig. 1b). Thus undoubtedly trypano-
somes are able to cross the endothelial cell layer and the
underlying basal lamina. Since it is not a question of the number
of parasites in blood, the latency of plexus infection cannot easily
be explained. To further explore this latency, we isolated brains
from infected rats 35 days p.i. to analyze the parasite’s
morphology. In this case, the brains were isolated without fixation
and macerated in media to release life parasites. Interestingly,
beside the regular slender and stumpy forms we knew from blood,
we observed a very slim and highly moveable form, clearly
different from morphological stages seen in blood samples before
(Fig. 2a). To further characterize this form, we prepared these
brain isolates for scanning EM and counted the length of all
morphological stages in 100 SEM micrographs to obtain a
statistically relevant impression of the length distribution (Fig. 2b).
For this purpose, Olympus cell‘F software was applied to measure
the correct length of the flagellum. From the results we considered
trypanosomes below 17 mm mm as stumpy, 17–23 mm as slender
and above 23 mm as a characteristic slim form from brain. To our
surprise, however, this form were also visible in blood, but
appeared with a considerable latency (Fig. 2c). Since this correlates
very well with the time of plexus appearance, we questioned
whether this morphological stage is needed for brain infection. For
this purpose rats have been intraperitoneally infected with donor
blood from an infected rat 28 days p.i. In this case, trypanosomes
were detected within the pial compartment 8 days after infection
(data not shown). This result indicates that either the slim
morphology differentiates in blood from slender parasites, or it is
formed in brain and appeared in blood analogously to a relapse.
To investigate whether the accumulation of immune complexes
can promote plexus infection, rats were immunized against
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of anti-VSG antibodies was demonstrated by Western blot analysis
(data not shown). To induce formation of antibody-antigen
complexes, rats were narcotized and 1 mg VSG was injected
intravenously over a period of 15 min. Afterwards, the rats were
infected with AnTaT 1.1 (which expresses an immunologically
different surface coat than the strain used for immunization). In
this case, no difference in brain infection was observed compared
with control animals receiving an i.p. infection. The result suggests
that concentrated immune complexes do not trigger brain
infection as a sole factor.
Since stroma contains plasma on its way to become csf,
substrate concentrations for e.g. glucose, amino acids, lipids and
even protein are very similar or identical to blood and the parasites
should find ideal conditions for growth. In contrast, growth inside
the choroid plexus seems rather limited, as judged from the
population density. Within stroma, we found trypanosomes
covered with VSG (Fig. 1c), but also naked parasites without coat
(Fig. 1b). Occasionally, we found coatless parasites within a stroma
cell (Fig. 1d). It is possible that either unspecific proteases are
present in stroma or that the coat is cleaved off by a trypanosomal
protease like MSP (see below). Alternatively, trypanosomes may
multiply, but because of the high local parasite concentration the
prostaglandin D2 concentration increases and induces apoptosis,
as described earlier [25,26,27]. In addition to its stroma location,
we detected parasites also within the ventricle, usually in close
vicinity to either epithelial cells or Kolmer cells [23] (Fig. 1e). The
number was low, but one should keep in mind that free swimming
trypanosomes within the ventricle would have been lost together
with the csf during preparation of the choroid plexus. In any case,
the results show that trypanosomes are able to cross not only the
fenestrated endiothelial cell layer but also the epithelial cell layer
and to enter the ventricle. Parasites within the ventricle looked
healthy and contained the VSG coat.
In principle, csf is a blood filtrate containing usually the same
constituents as serum, mostly in a lower, sometime in a higher
concentration [28]. Therefore, despite the fact that glucose, the
main carbon source for trypanosomal energy metabolism, is
reduced by 30 to 50% as compared with blood, csf should support
survival of trypanosomes perfectly well.
Csf as culture medium for bloodstream trypanosomes
We used isolated csf from different sources: 1) human csf was
obtained with patients consent from hospital as surplus materials
removed for other purposes; 2) rat csf (400 ml) was obtained from
an animal sacrificed because of a hydrocephalus; 3) csf (up to
150 ml per rat) was obtained from sacrificed rats [29]. In the first 2
cases clear csf was obtained, while in the latter case blood
contamination could not be avoided, but did not exceed 20% of
the volume. These rats had been sacrificed by CO2 treatment to
avoid a possible contamination with barbiturates. In any case,
trypanosomes could not grow in csf. Instead, the cell number
decreased slowly within the next 10 h and rapidly thereafter.
Addition of 33 mM glucose showed no effect (data not shown)
while addition of 50% HMI-9 medium [30] increased survival
time to about 50 h (Fig. 3).
In contrast, culture medium diluted 1:1 with Ringer solution
had no impact on trypanosome survival as compared with
undiluted medium, obviously because it contains an excess of all
necessary components (Fig. 3). This result suggests that in csf a
constituent is toxic to trypanosomes, rather than that an essential
component is missing. As compared with control cells in culture
medium, trypanosomes cultured in csf showed a reduced
Figure 1. Electron micrographs showing the distribution of trypanosomes in the choroid plexus and ventricle system more than 20
days after a blood infection. a, A representative micrograph showing a trypanosome (T) within the lumen (L) of a brain microvessel; no
trypanosomes were found beyond the blood-brain barrier within the brain parenchyma (BP). b, Cross-section of the choroid plexus showing a
fenestrated blood vessel (fV) and trypanosomes (T) within lumen and stroma (S); E, erythrocyte. Trypanosomes inside the blood vessel contain the
VSG coat, while parasites in stroma are naked. c, Trypanosomes (T) in the stroma (S) between fenestrated capillaries (fV) containing the VSG surface
coat. Note: in Figs a–c the brain was directly fixed by perfusion with glutaraldhyde prior to isolation. d, A trypanosome (T) inside a plexus cell within a
lysosome suggesting phagocytosis of coatless trypanosomes. Trypanosomal and lysosomal membranes are labelled by double arrows. e, Low
magnification of a choroid plexus showing the ventricle (V), plexus epithelial cells (PEC) and, in the stroma, a fenestrated capillary (fV) with a
trypanosome (T). KC=Kolmer cell. f, Detail of the apical region of a plexus epithelial cell showing two trypanosomes (T) in close proximity of the
microvilli of an epithelial cell and a Kolmer cell (KC), respectively.
doi:10.1371/journal.pone.0034304.g001
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necrotic cell death.
A place for trypanosomes to hide out
Since our experimental data revealed that trypanosomes cannot
settle permanently in the plexus or in csf, we considered it likely
that they move with the csf current to the subarachnoid space
and/or the Virchow-Robin space (VRS). Underneath the cranium
three linings of the brain are found: Dura mater, arachnoidea mater and
pia mater. The space between arachnoidea and pia mater, the
subarachnoid space is completely filled with csf. The VRS is an
extension of the subarachnoid space that surrounds blood vessels
emerging from arachnoid vessels to enter the brain. Thus the VRS
follows the blood vessel for a short distance and ends blindly; its
wall is formed from pia mater [31,32,33]. Analyzing the
subarachnoid space and VRS by electron microscopy studies, we
easily detected large numbers of trypanosomes within the pia mater
that consists of up to six pial cell layers and the extracellular matrix
[34]. Our EM micrographs clearly show that trypanosomes are
found in the subarachnoid space (Fig. 4a), from where they move
between pial cells (Fig. 4b) and settle there (Fig. 4c). In this area the
parasites consistently contained the VSG coat, showed no
Figure 2. Changes of trypanosomal morphology during the
course of infection. a, Scanning electron micrographs of typical
stumpy, intermediate and slender form trypanosomes. The size of the
pictured trypanosome is 17 mm, 22 mm and 26 mm, respectively. b,
Blood samples of 3 infected rats were analyzed for trypanosome titer up
to 20 days (¤ [cells/ml]), shown is a representative curve. Additionally,
the overall length of the parasites (n=27) was measured and grouped
into stumpy forms (up to 17 mm), intermediate forms (17–23 mm) and
slender forms (longer than 23 mm). Intermediate forms (& [%])
represent proliferating trypanosomes. Slender forms (m [%]) increase
continuously at low level during the course of infection and reach up to
40% after 20 days p.i. Distribution of stumpy forms is not explicitly
shown but can be calculated as the difference to 100%. c, Comparison
of trypanosomes isolated from blood or brain of infected rats. AnTat1.1
has been isolated from rat blood (4 days p.i., red bars) and rat brain (35
days p.i., blue bars). The overall length of parasites (n=96) was
measured from the back of the trypanosome to the tip of the flagellum
(see inset). We here show that the brain isolate contains a significant
amount of trypanosomes longer than 23 mm.
doi:10.1371/journal.pone.0034304.g002
Figure 3. Comparison of trypanosome survival times in
cerebrospinal-fluid and/or HMI-9 medium. AnTat1.1 was isolated
11 days p.i. from rat blood, separated from blood cells and adjusted to a
cell density of 5*10
4 parasites in 100 ml of the respective solution.
Contamination of csf with blood did not exceed 20%, as judged from
the erythrocyte count. Rattus norvegicus csf supported survival of the
parasites only for some 30 hours (m) and could not be prolonged by
supplementing 33 mM glucose (data not shown). However, in a mixture
of csf and HMI-9 medium (1:1), trypanosomes survived significantly
longer (i.e. approx. 45 h, &). As HMI-9 medium (¤) contains all nutrients
in excess, it supports growth of trypanosomes for approximately 56 h,
even if diluted with saline solution (1:1, X).
doi:10.1371/journal.pone.0034304.g003
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were often densely packed (Fig. 4d). We frequently observed
dividing stages (Fig. 4f), but never detected intracellular trypano-
somes, although VRS is known to contain macrophages and
lymphocytes [35]. Pial cells lay on top of the glia limitans or moved
inside the dilated glia limitans, i.e. the border to the brain
parenchyma (Fig. 4e). Thus the trypanosomes have not entered
the brain, but stayed outside the blood and csf systems, finding
access to the foremost border of the brain. From here the parasite’s
metabolic waste (like pyruvate) should be removed by diffusing to
csf. On the other hand, secreted signal molecules like PGD2 will
limit trypanosome cell density in this limited space, but would also
distributed throughout csf to influence sleep-wake behavior
[26,36,37,38]. It should be noted that in late stage patients a
highly elevated concentration of PGD2 was detected previously
[15].
Discussion
We used electron microscopy studies to investigate the
consecutive steps of trypanosomal brain infection. Our findings
show that trypanosomes first penetrate the BCB while no
penetration of the BBB has been detected. Inside the choroid
plexus, trypanosomes were localized within the blood capillaries
and inside the stroma. Interestingly, some trypanosomes in stroma
had no surface coat and showed disintegration of the plasma
membrane. Occasionally, we also detected coatless trypanosomes
inside stroma cells within a lysosome, but these parasites were
obviously phagocytized and not, as suggested earlier [39], an
intracellular stage. From our result we assume that stroma is a
rather hostile environment and trypanosomes have to move out
quickly to survive. This would explain the low density of
trypanosomes within the choroid plexus. Why some but not all
of the parasites that entered the plexus lost their VSG coat remains
speculative, but may just be a matter of time. If a parasite dies in
stroma, loss of membrane integrity would activate the GPI-specific
phospholipase C to cleave the coat off [40]. In order to survive,
trypanosomes have to cross the epithelial cell layer to reach the
ventricle. We have not seen a parasite between or inside epithelial
cells, but, as judged from their morphological integrity, we found
intact trypanosomes inside the ventricle. Our experiments to
cultivate trypanosomes in csf clearly revealed that they cannot
multiply or survive for long. This observation is consistent with an
earlier report [41]. Thus it is rather unlikely that a considerable
population density, comparable with blood infection, can be
reached in csf. From this perspective it becomes also clear why
lumbal puncture has a limited benefit as a diagnostic tool: As
published recently [42], the number of trypanosomes in csf
obtained by lumbal puncture from HAT patients is usually zero or
very low, and thus lymphocytes are often counted as a general
marker for inflammation, which together with HAT symptoms are
indicative for late stage disease.
For a sustained survival in brain, trypanosomes have to reach a
more convenient location, apart from plexus and csf. Our
experimental data show that parasites do not enter the brain
parenchyma, but reside inside the pia mater close to the glia limitans.
Thus parasites living in this location should be supported by
substrates like glucose, amino acids, lipids and nucleosides, while
being protected from dangerous components of csf. Unlimited
growth of these trypanosomes would certainly be dangerous for
the host. However, cell density control by PGD2-induced apoptosis
[16,17,26] limits the risk by avoiding inflammation reactions. In
addition, secreted PGD2 could easily be distributed via csf and
could induce the observed disruption of sleep wake cycles. With
time, trypanosomes may find their way across the glia limitans to
invade the parenchyma. Here, contact with microglia cells could
lead to inflammation [43] and eventually cause lymphocytes to
enter the brain. It should be noted that in many cases people seem
to die prior to this stage, i.e. before encephalitis is observed [19].
We thus hypothesize that breakdown of the BBB at the final stage
of brain infection is the result of an inflammation and not induced
by the infiltration of parasites from the blood side. Instead of
moving forward from its pial location to enter the brain,
trypanosomes may also move backwards into csf and further to
blood by crossing the arachnoid villi during csf resorption. This
could account for relapses occurring after clearance of blood
Figure 4. Electron micrographs showing the location of
trypanosomes more than 20 days after blood infection. a,
Trypanosomes (T) are in close proximity to pial cells (PC) within the
subarachnoid space (SAS); BP brain parenchyma. b, Trypanosomes (T)
are located intimately between pial cells (PC) at the intersection
between subarachnoid space and pia mater. c, Area of the pia mater
containing densly packed trypanosomes between pial cells. A, astroglial
endfeet forming the glia limitans; SAS, subarachnoid space. d, Detail of
c. Astrocytes (A) forming the glia limitans (lower line of vertical arrows).
The upper line of vertical arrows marks the mesothelium. The horizontal
arrow labels a tight junction between two pial cells. Trypanosomes (T)
are seen between pial cells. e, Glia limitans (labelled by two arrows)
marks the border between brain parenchyma (BP) and pia mater (PM);
A, foot of an astrocyte. In this image trypanosomes (T) are located
within the dilated glial limitans (asterisks). f, A trypanosome located
between pial cells (PC). The two arrows point to the two flagella
proving that the parasites are capable of cell division at this location.
doi:10.1371/journal.pone.0034304.g004
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observed blood infection after intrathecal injection of parasites into
the ventricle. We cannot exclude that trypanosomes may also
enter the pial compartment from leptomeningeal vessels, but
regard this possibility as rather unlikely considering the confirma-
tion of the plexus–ventricle route.
To our knowledge, it has so far not been attempted to apply
trypanocidal drugs (like suramin or pentamidin) by intrathecal
injection using lumbal puncture. Considering the parasites
location in the pial and subpial compartment, it might be
worthwhile to explore this possibility that is successfully used for
intrathecal chemotherapy of brain tumor patients, to treat HAT.
The question remains why trypanosomes cross the BCB but not
the BBB. An explanation in this respect may come from the
constitution of the BBB versus BCB. Usually, the BBB cannot be
penetrated by cells while biochemical compounds need specific
carrier proteins. It is known that in case of inflammation
lymphocytes are able to cross the BBB, but in this case specific
cell-cell interactions are indispensable to open the gate temporarily
[44]. It has been discussed that trypanosomes could just follow
lymphocytes or that they can open the BBB temporarily using
small molecules like c interferon [45]. Both possibilities seem
unlikely to us. Lymphocytes perform a highly sophisticated
strategy to penetrate either para- or trans-cellular [46], but in
any case, one lymphocyte enters as an individual cell, while the
gap is closed afterwards. Also, for a trypanosome to follow a
lymphocyte, a brain inflammation must have been occurred
previously due to another event like injury or a different infection.
The small molecule theory suggests that a high local concentration
of parasites within the blood vessels would induce themselves or
host cells to secrete this molecule, rendering it difficult to explain
the latency of brain infection. Also, existence of a parasite specific
factor to open the BBB has not been substantiated so far.
In terms of the BCB, the situation is different. Here blood
vessels are lined with fenestrated endothelial cells, while a glia
limitans, composed from a basal lamina and attached astrocytes, is
missing. Thus the barrier is less dense and blood pressure allows
the liquid parts of blood to expand into the choroid plexus. Using
flagella movement, trypanosomes may orientate themselves to this
current and penetrate. Since flagella movement pulls a trypano-
some forward, it is likely that the free end of the flagellum
undergoes cell contact with the fenestrated endothelial cells first to
open the gate. However, it takes some 20 days of infection before
this process happens, and thus some additional factor seems to be
needed. It has been described for other diseases [47] and suggested
for HAT [48] that antigen-antibody complexes (in this case the
VSG-antibody complex) may concentrate inside the plexus, thus
leading to inflammation and weakening of the endothelial
fenestration. This could indeed account for the observed latency,
although one might expect that blood cells would also enter the
plexus in this case. In our preliminary experiments, induction of
VSG-antibody complexes did not result in a more rapid brain
infection, indicating that vsg-antibody complexes do not account
for the observed latency. Nevertheless, crossing the blood plexus
border is only half of the way to reach csf. The border between
plexus and ventricle is built from epithelial cells firmly connected
by tight junctions. It has been observed earlier that trypanosomes
not only enter the brain but can also be found in testis [49]. The
respective blood-testis barrier is formed from Sertoli cells.
Interestingly, tight junctions between plexus epithelia as well as
Sertoli cells contain claudin-11 [24], which leads to formation of a
more parallel orientation of the junctional strands as seen in
freeze-fracture replicas, while all other tight junctions show a
branched appearance of strands [50]. It is tempting to speculate
that trypanosomes may have developed the ability to specifically
interact with claudin-11, but this has to be investigated in detail.
Both parts of the BCB contain, in addition to the respective cell
layers, a basal lamina that has to be penetrated. From the
movement of cancer cells during metastasis it is known that
metalloproteases are able to open a basal lamina [51]. Since
bloodform trypanosomes are able to express suitable metallopro-
teases (MSPs) [52], the basal lamina may be easily crossed by this
parasite. TbMSP-B may also account for the loss of the VSG coat
on individual parasites within stroma.
The presented scenario how trypanosomes invade the brain is
based on our experimental findings and can explain several
observations describing sleeping sickness. It cannot explain,
however, why it takes some 20 days in our animal model, or
weeks to months in nature, until the parasites enter the choroid
plexus. We found a very thin and fast moving slender form that we
observed during late peak populations in blood, which was also the
predominant form of trypanosomes isolated from brain. It is
tempting to speculate that an additional lifecycle stage exists that is
especially adopted to live in brain. This would also explain why we
did not find a brain infection by intrathecal injection of bloodform
trypanosomes into the brain. Nevertheless, we consider the three
morphological stages shown in Fig. 2a rather as slender,
intermediate and stumpy, leading to the consequence that
intermediate trypanosomes would be the major form to support
blood infection, while slender parasites are involved in brain
infection, and stumpy parasites die either by apoptosis or are
opsonized by antibodies and phagocytized by macrophages. This
view on the different roles of the 3 morphological stages in blood is
supported by the fact that stumpy parasites do not undergo
antigenic variation or cell division [53] and that formation of
monomorphic strains (induced by an exclusive blood to blood
infection of laboratory animals) leads to parasites of an
intermediate rather than slender morphology. The question of
the physiological function of slender form trypanosomes is
currently addressed in our laboratories. One might ask why the
infected blood samples used to infect our laboratory animals did
not contain slender parasites. The reason is that we prepare
stabilates (blood samples to be stored in liquid nitrogen and used
for animal infection) always from an infected rat during the first
parasitaemic wave, i.e. at a time when slender parasites have not
been formed yet, and in nature a mammal infection starts with the
metacyclic insect form. Consistent with this considerations, a pial
infection appeared before day 10 (instead of day 20), if infection of
rats was not performed using regular stabilates but infected blood
from rats infected for more than 20 days.
In conclusion we show that part of the trypanosome population
escapes from blood by crossing the BCB eventually finding their
way to the pial and subpial space. Here, i.e. still outside the brain
parenchyma, the parasite finds an ideal place being protected from
all means of the immune response with the option to reinvade
blood. In well adapted hosts like trypano-tolerant animals, this
might be the final destination to ensure a lifelong infection. In
suboptimal adapted hosts like human, finally the parasite may
cross the glia limitans at a later stage of infection, leading to
encephalitis and death.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the German
Animal Welfare Act. The protocol was approved by the Regional
Commission of Tu ¨bingen (Permit Number: IB 3/10). All surgery
was performed under ketamin/xylazin anesthesia, and all efforts
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e34304were made to minimize suffering. For experiments with surplus csf,
patients were educated as recommended by the ethics committee
at the University Hospital of Tu ¨bingen. This committee approved
the usage of surplus csf for the presented study. Written informed
consent was provided by study participants.
Isolation of trypanosomes from blood or brain. Rats
were infected intraperitoneally with 5610
7 cells, mice with 5610
6
cells. The parasite titer was monitored daily by tail biopsy. After
defined time periods, animals were narcotized with ketamin
(100 mg/kg body weight)/xylazin (10 mg/kg body weight), 1 ml
citrate glucose anticoagulant (CGA; 102 mM citrate, 40 mM
glucose, pH 7.7) was given into the opened thorax to prevent
blood clotting. The vena cava was cut and the escaping blood was
kept on ice. Trypanosomes were purified by ion-exchange
chromatography [54] and fixed in paraformaldehyde (4% w/v)
/ glutaraldehyde (4% v/v). Blood circulation was flushed with
CGA, brains were dissected, chopped and incubated in 20 ml
HMI-9. Tissue was removed by filtration and the trypanosomes
fixed as above.
Brain isolation. To analyze trypanosomal brain infection,
infected animals were narcotized before opening the thorax.
Placing a syringe needle, connected to a buffer reservoir, into the
left heart ventricle, the vessel system was extensively washed by
perfusion with a glucose containing isotonic phosphate buffer that
was replaced by a fixative solution containing paraformaldehyde/
glutaraldehyde (4% each) thereafter. In some cases, perfusion was
directly performed with a glutaraldehyde containing isotonic salt
solution, to also fix cells within vessels.
Intrathecal Injection. For intrathecal injection narcotized
rats were positioned into a stereotaxic instrument (Narishige
scientific instruments). The injection site was localized with the aid
of a rat brain atlas [55]. Trypanosomes (10
4 parasites in 5 ml) were
injected with a pulsed micropump (Picospritzer III, Parker Hanifin
Corporation) at a rate of 250 nl/min. The fixed brain was frozen
in tissue medium (NEG 50
TM, Thermo scientific) and stored at
280uC for cutting frozen sections of 10–30 mm thickness with a
cryostat microtome.
Transmission electron microscopy. Tissues were post-
fixed in osmiumtetroxide (1%) in cacodylate buffer. After three
washes with D-PBS the samples were dehydrated by a graded
ethanol series (30%, 50%, 70%, 90%, 96% for 15 min each,
2699% for 30 min each) and two washes with propylenoxide.
During the 70% ethanol step of the graded ethanol series, the
specimens were incubated in saturated uranyl acetate. After
completion of dehydration, the preparations were embedded in
Araldite 502 (Sigma-Aldrich) at 60uC for 48 h. Ultrathin sections
were prepared on a Leica FCR Ultracut ultramicrotome and
stained with lead citrate. Sections were examined using a Zeiss EM
10 electron microscope [56].
Scanning electron microscopy [57]. Samples were fixed
with 2.5% glutaraldehyde in cacodylate buffer, postfixed with 1%
osmium tetroxide in phosphate-buffered saline, dehydrated in a
graded series of ethanol and critical-point-dried using CO2. After
critical point drying they were fixed on specimen holder stubs,
sputter-coated with gold, and viewed with a scanning electron
microscopy (SEM) (Cambridge Stereoscan 250 Mk2, Cambridge
Scientific, Cambridge, UK).
Immunization of rats against variant surface
glycoprotein. Rats received initially 100 mg VSG in 100 ml
Freund’s complete adjuvant subcutaneously and were boosted
once after 15 days. After 40 days the existence of anti-VSG
antibodies was proven using Western blot analysis.
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